The Chilean forestry and paper products company reported mixed performance across its business segments, with its stock trading at 1,438 Chilean pesos, up 0.4% on the day of the presentation.

The Company reported a net loss of approximately $6.4 million, or $0.13 per share, for the three months ended March 31, 2025, ...

FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...

May 12, 2025Sonida Senior Living, Inc. beats earnings expectations. Reported EPS is $-0.77, expectations were $-0.95.

ADC Therapeutics SA (NYSE: ADCT) Q1 2025 Earnings Call Transcript May 14, 2025 ADC Therapeutics SA beats earnings ...

MediPharm Labs Corp. (MEDIF Q1 2025 Earnings Conference Call May 14, 2025 10:00 AM ETCompany ParticipantsDavid Pidduck - President & Chief ...

PRINCETON, NJ, USA I April 26, 2025 I UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and ... as a targeted treatment for NMIBC with an acceptable safety profile.

There’s a place in Nashville where the fox isn’t running from the hounds – it’s brewing some of the most talked-about root ...

The Company has been selected to deliver an oral presentation on the translational data from its Phase 1 clinical trial of FT522, an off-the-shelf, CD19-targeted CAR NK cell product candidate ...